Impetigo-Pipeline Review, H2 2016
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
Description Impetigo is a highly contagious skin condition. Impetigo is caused by two bacteria streptococcus pyogenes and staphylococcus aureus. Symptoms include fluid-filled blisters, itchy rash, skin lesions and swollen lymph nodes. Risk factors include skin-to-skin contact, injury to the skin, having diabetes and having a compromised immune system. Treatment includes antibiotics. Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/148547 . Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Impetigo – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Impetigo (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Impetigo (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Impetigo and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III and Phase II stages are 1, 1 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.Impetigo. Impetigo (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/148547 . For more information contact sales@orbisresearch.com Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Impetigo (Infectious Disease). - The pipeline guide reviews pipeline therapeutics for Impetigo (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
activities. - The pipeline guide reviews key companies involved in Impetigo (Infectious Disease) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Impetigo (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Impetigo (Infectious Disease) Browse Complete Report @ http://www.orbisresearch.com/reports/index/impetigo-pipeline-reviewh2-2016 . List of Figures Number of Products under Development for Impetigo, H2 2016 7 Number of Products under Development for Impetigo - Comparative Analysis, H2 2016 8 Number of Products under Development by Companies, H2 2016 9 Comparative Analysis by Late Stage Development, H2 2016 11 Assessment by Monotherapy Products, H2 2016 20 Number of Products by Targets, H2 2016 21 Number of Products by Stage and Top 10 Targets, H2 2016 21 Number of Products by Mechanism of Actions, H2 2016 23 Number of Products by Stage and Mechanism of Actions, H2 2016 23 Number of Products by Routes of Administration, H2 2016 25 Number of Products by Stage and Routes of Administration, H2 2016 25 Number of Products by Molecule Types, H2 2016 27 Number of Products by Stage and Molecule Types, H2 2016 27 For any enquires before buying, connect with us @ enquiry@orbisresearch.com About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: Hector Costello Senior Manager – Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019
Phone No.: +1 (214) 884-6817; +9164101019 Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research Follow us on Twitter: https://twitter.com/orbisresearch Like us on Facebook: https://www.facebook.com/OrbisResearch
www.orbisresearch.com; +1 (214) 884-6817; +9120-64101019